Dr. Clay Siegall is more than your average doctor, he is a man of many acts. Thanks to having an extensive educational background, this extraordinary man is known by many people as a doctor, a philanthropist, a mentor, a scientist, an entrepreneur and an author. Siegall is well-known in the cancer research community because he has done so much to better mankind. Siegall is the CEO and president of Seattle Genetics, which is one of the leading oncology biotech companies in the world. The company specializes in developing antibody-based therapies for cancer treatment. Located in Bothell, Washington, Seattle Genetics employs an estimated 1,000 employees.
When it comes to taking a more progressive approach to fighting this disease, few people can outperform Siegall. This guy has a strong passion for what he believes in, and he has the perseverance to fully-stay the course. Siegall has been working in this exlusive community for more than 30 years. Bristol Myers Squibb, the National Institute of Health and the National Cancer Institute have all benefited from his wide range of services. Proving great leadership is the name of the game and Siegall personifies this the best. His love for fighting cancer came into fruition when he was in college. During this time, his father was being treated for the disease, and he saw just how harsh these treatments could be. Siegall made a vow to himself to make a change for the better and this is how Seattle Genetics came to be.
This company has some of the highest of quality antibody-based therapies. ADCETRIS is the company’s flagship drug, and it is currently being used all around the world. Thanks to Seattle Genetics’ progressive approach, the company has at least 20 new advanced drugs in its pipeline. The future looks very bright in the fight against cancer and Dr. Clay Siegall will continue to steer the ship to even more success.